Abstract | BACKGROUND: METHODS: A de novo unbiased screening approach based on selection of highly bone metastatic breast cancer cells in vivo was used to determine copy number aberrations (CNAs) associated with bone metastasis. The CNAs associated with bone metastasis were examined in independent primary breast cancer datasets with annotated clinical follow-up. The MAF gene encoded within the CNA associated with bone metastasis was subjected to gain and loss of function validation in breast cancer cells (MCF7, T47D, ZR-75, and 4T1), its downstream mechanism validated, and tested in clinical samples. A multivariable Cox cause-specific hazard model with competing events (death) was used to test the association between 16q23 or MAF and bone metastasis. All statistical tests were two-sided. RESULTS: CONCLUSIONS:
|
Authors | Milica Pavlovic, Anna Arnal-Estapé, Federico Rojo, Anna Bellmunt, Maria Tarragona, Marc Guiu, Evarist Planet, Xabier Garcia-Albéniz, Mónica Morales, Jelena Urosevic, Sylwia Gawrzak, Ana Rovira, Aleix Prat, Lara Nonell, Ana Lluch, Joël Jean-Mairet, Robert Coleman, Joan Albanell, Roger R Gomis |
Journal | Journal of the National Cancer Institute
(J Natl Cancer Inst)
Vol. 107
Issue 12
Pg. djv256
(Dec 2015)
ISSN: 1460-2105 [Electronic] United States |
PMID | 26376684
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author 2015. Published by Oxford University Press. |
Chemical References |
- Biomarkers, Tumor
- MAF protein, human
- Proto-Oncogene Proteins c-maf
|
Topics |
- Animals
- Biomarkers, Tumor
(metabolism)
- Bone Neoplasms
(metabolism, secondary)
- Breast Neoplasms
(metabolism, pathology)
- Cell Line, Tumor
- DNA Copy Number Variations
- Female
- Gene Expression Regulation, Neoplastic
- Heterografts
- Humans
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Incidence
- Mice
- Mice, Inbred BALB C
- Odds Ratio
- Predictive Value of Tests
- Prognosis
- Proportional Hazards Models
- Proto-Oncogene Proteins c-maf
(metabolism)
- Up-Regulation
|